SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
Exxon, LyondellBasell Eye Shell’s $8 Billion U.S. Chemicals Assets 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
Alibaba Raises $10.2 Billion to Expand AI Infrastructure 
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
Nvidia Options Price in $280 Billion Earnings Swing 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Ampol Profit Surges as Refining Margins Hit Record Highs 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
KPMG Australia Cuts 5% of Workforce Amid Scandal 
California Seeks Paramount Divestitures in Warner Bros. Merger 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
Add as a preferred source on Google
CARLSBAD, Calif., May 02, 2018 -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that President and Chief Executive Officer, Hany Massarany, will present at the Bank of America Merrill Lynch 2018 Health Care Conference in Las Vegas, NV.
Mr. Massarany is scheduled to present on Wednesday, May 16 at 9:20 a.m. Pacific Time. Interested parties may access a live and archived webcast of the event at ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ:GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor® detection technology, GenMark's eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.
Investor Relations Contact
Lynn Pieper Lewis or Leigh Salvo
(415) 937-5404
[email protected]
